Mirvaso - Brimonidine tartrate 5 mg / g Gel 30 g

Reference details for licensed healthcare facility review and verification.

NDC 1100299-5980-30
Product NDC00299-5980
Generic Drug Namebrimonidine tartrate
Brand NameMirvaso
ManufacturerGalderma Laboratories, L.P.
Strength5 mg / g
Dosage FormGel
Drug TypeTopical
Package Quantity30 g
Package Description30 g in 1 TUBE (0299-5980-30)
Active IngredientsBrimonidine Tartrate
Marketing CategoryNDA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

NDC snapshot

brimonidine tartrate 5 mg / g Gel is tracked under NDC 00299-5980-30 and rolls up into product family 00299-5980. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.

  • Package configuration: 30 g.
  • Manufacturer: Galderma Laboratories, L.P..
  • Dosage form: Gel.
  • Family size: 5 indexed presentations.

Click a tag to refine the catalog view around this product reference.

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Alternate presentations in this family

These nearby package-level pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.

Mirvaso - Brimonidine tartrate 5 mg / g Gel 30 g, NDC 00299-5980-30, is a Galderma Laboratories, L.P. 5 mg / g gel presentation packaged as 30 g.

NDC search formats

  • Canonical NDC 11: 00299-5980-30
  • Digits-only NDC 11: 00299598030
  • Possible 10-digit display format: 0299-5980-30 (0299598030)

Helpful product links